SCHEMBL20005697

SCHEMBL20005697

C=CCOc1ccc(/C=C2\SC(=S)N(c3ccc(OCC)cc3)C2=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DUSP26 Q9BV47 1/20 0.65
▸ MAPT P10636 7/20 0.58
▸ ALDH1A1 P00352 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ LMNA P02545 1/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ IKBKB O14920 7/20 0.58
▸ MEN1 O00255 5/20 0.58
▸ KMT2A Q03164 5/20 0.58
▸ MITF O75030 2/20 0.58
▸ NCOA3 Q9Y6Q9 2/20 0.58
▸ NPC1 O15118 1/20 0.58
▸ MAPK1 P28482 1/20 0.57
▸ CACNA1B Q00975 1/20 0.57
▸ APBA1 Q02410 1/20 0.57
▸ POLB P06746 2/20 0.55
▸ NSD2 O96028 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ RAB9A P51151 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18103077 1.00 DUSP26 (0.65) DUSP26MAPTALDH1A1KDM4ELMNA
SCHEMBL18102922 0.85 DUSP26 (0.58) DUSP26MAPTALDH1A1KDM4ELMNA
SCHEMBL18102934 0.81 DUSP26 (0.75) DUSP26MAPTIKBKBMEN1KMT2A
SCHEMBL5281534 0.78 MAPK1 (0.72) MAPTALDH1A1KDM4ELMNANPSR1
SCHEMBL5281527 0.78 MAPK1 (0.72) MAPTALDH1A1KDM4ELMNANPSR1
SCHEMBL5281537 0.78 MAPK1 (0.72) MAPTALDH1A1KDM4ELMNANPSR1
SCHEMBL18103079 0.77 MAPK1 (0.78) MAPTALDH1A1KDM4ELMNANPSR1
SCHEMBL20006042 0.77 MAPK1 (0.78) MAPTALDH1A1KDM4ELMNANPSR1
SCHEMBL20006090 0.76 DUSP22 (0.80) DUSP26MEN1KMT2ARAB9ABCL2
SCHEMBL18103078 0.76 DUSP22 (0.80) DUSP26MEN1KMT2ARAB9ABCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same UNIVERSITY OF MIAMI (US) 2019-12-10 — — US disclosed
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same NOTCH1, CBFB, HES1 DUSP26 2207/4885MAPT 3938/4885ALDH1A1 2177/4885
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NOTCH1, CBFB, HES1 DUSP26 2207/4885MAPT 3938/4885ALDH1A1 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback